BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan X, Guo Y, Wang L, Xiong X, Zhu L, Fang K. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. Int J Nanomedicine 2016;11:3939-50. [PMID: 27574424 DOI: 10.2147/IJN.S112951] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Zahiri M, Taghavi S, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M. Theranostic nanobubbles towards smart nanomedicines. J Control Release 2021;339:164-94. [PMID: 34592384 DOI: 10.1016/j.jconrel.2021.09.032] [Reference Citation Analysis]
2 Zhu L, Guo Y, Wang L, Fan X, Xiong X, Fang K, Xu D. Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs. J Nanobiotechnology 2017;15:63. [PMID: 28962657 DOI: 10.1186/s12951-017-0307-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
3 Huang H, Dong Y, Zhang Y, Ru D, Wu Z, Zhang J, Shen M, Duan Y, Sun Y. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer. Theranostics 2019;9:1047-65. [PMID: 30867815 DOI: 10.7150/thno.29820] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
4 Wu M, Zhao H, Guo L, Wang Y, Song J, Zhao X, Li C, Hao L, Wang D, Tang J. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer. Drug Deliv 2018;25:226-40. [PMID: 29313393 DOI: 10.1080/10717544.2017.1422300] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
5 Li P, Jin L, Feng L, Wang Y, Yang R. ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis. Sci Rep 2021;11:16508. [PMID: 34389762 DOI: 10.1038/s41598-021-96042-y] [Reference Citation Analysis]
6 Gugnoni M, Ciarrocchi A. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer. Int J Mol Sci 2019;20:E1924. [PMID: 31003545 DOI: 10.3390/ijms20081924] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 22.3] [Reference Citation Analysis]
7 Li Y, Duo Y, Bao S, He L, Ling K, Luo J, Zhang Y, Huang H, Zhang H, Yu X. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. Int J Nanomedicine 2017;12:6239-57. [PMID: 28894364 DOI: 10.2147/IJN.S143293] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 5.4] [Reference Citation Analysis]
8 Wang Y, Lan M, Shen D, Fang K, Zhu L, Liu Y, Hao L, Li P. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer. Int J Nanomedicine 2020;15:4289-309. [PMID: 32606678 DOI: 10.2147/IJN.S243548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 Gu F, Hu C, Xia Q, Gong C, Gao S, Chen Z. Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer. J Nanopart Res 2018;20:303. [PMID: 30524190 DOI: 10.1007/s11051-018-4407-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
10 Zhu L, Wang L, Liu Y, Xu D, Fang K, Guo Y. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors. Int J Nanomedicine 2018;13:6481-95. [PMID: 30410333 DOI: 10.2147/IJN.S176287] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ding Y, Cao Q, Qian S, Chen X, Xu Y, Chen J, Shen H. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. J Ultrasound Med 2020;39:761-73. [PMID: 31702068 DOI: 10.1002/jum.15155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Feng X, Zhu Y, Wang F, Guo T, Dou X, Lin M, Tian W, Singh V. The Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy. Journal of Nanomaterials 2022;2022:1-17. [DOI: 10.1155/2022/9946357] [Reference Citation Analysis]
13 Wu M, Wang Y, Wang Y, Zhang M, Luo Y, Tang J, Wang Z, Wang D, Hao L, Wang Z. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer. Int J Nanomedicine 2017;12:5313-30. [PMID: 28794625 DOI: 10.2147/IJN.S136032] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 7.4] [Reference Citation Analysis]
14 Wang Y, De Leon AC, Perera R, Abenojar E, Gopalakrishnan R, Basilion JP, Wang X, Exner AA. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA. Sci Rep 2021;11:4726. [PMID: 33633232 DOI: 10.1038/s41598-021-84072-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Maimaitiyiming Y, Hong F, Yang C, Naranmandura H. Novel insights into the role of aptamers in the fight against cancer. J Cancer Res Clin Oncol 2019;145:797-810. [PMID: 30830295 DOI: 10.1007/s00432-019-02882-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
16 Hu X, Zang X, Lv Y. Detection of circulating tumor cells: Advances and critical concerns. Oncol Lett 2021;21:422. [PMID: 33850563 DOI: 10.3892/ol.2021.12683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ye Y, Zhang L, Dai Y, Wang Z, Li C, Peng Y, Ma D, He P. PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer. Int J Nanomedicine 2020;15:7173-84. [PMID: 33061374 DOI: 10.2147/IJN.S268398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Johansen ML, Perera R, Abenojar E, Wang X, Vincent J, Exner AA, Brady-Kalnay SM. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents. Int J Mol Sci 2021;22:1983. [PMID: 33671448 DOI: 10.3390/ijms22041983] [Reference Citation Analysis]
19 Cruz-hernández CD, Rodríguez-martínez G, Cortés-ramírez SA, Morales-pacheco M, Cruz-burgos M, Losada-garcía A, Reyes-grajeda JP, González-ramírez I, González-covarrubias V, Camacho-arroyo I, Cerbón M, Rodríguez-dorantes M. Aptamers as Theragnostic Tools in Prostate Cancer. Biomolecules 2022;12:1056. [DOI: 10.3390/biom12081056] [Reference Citation Analysis]
20 Wu R, Yang X, Li X, Dong N, Liu Y, Zhang P. Nanobubbles for tumors: Imaging and drug carriers. Journal of Drug Delivery Science and Technology 2021;65:102749. [DOI: 10.1016/j.jddst.2021.102749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Tang W, Yang Z, Wang S, Wang Z, Song J, Yu G, Fan W, Dai Y, Wang J, Shan L, Niu G, Fan Q, Chen X. Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer Therapy. ACS Nano 2018;12:2610-22. [PMID: 29451774 DOI: 10.1021/acsnano.7b08628] [Cited by in Crossref: 136] [Cited by in F6Publishing: 136] [Article Influence: 34.0] [Reference Citation Analysis]
22 Lv W, Shen Y, Yang H, Yang R, Cai W, Zhang J, Yuan L, Duan Y, Zhang L. A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer. J Immunol Res 2018;2018:6202876. [PMID: 29854844 DOI: 10.1155/2018/6202876] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Bouvier-Müller A, Ducongé F. Application of aptamers for in vivo molecular imaging and theranostics. Adv Drug Deliv Rev 2018;134:94-106. [PMID: 30125606 DOI: 10.1016/j.addr.2018.08.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
24 Taki S, Ardestani MS. Novel nanosized AS1411-chitosan-BODIPY conjugate for molecular fluorescent imaging. Int J Nanomedicine 2019;14:3543-55. [PMID: 31190811 DOI: 10.2147/IJN.S202561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Liu Y, Zeng S, Xu R. Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer. Front Oncol 2022;12:905087. [DOI: 10.3389/fonc.2022.905087] [Reference Citation Analysis]